Anupam Rasayan India Limited (ANURAS) completes acquisition of Bliss GVS Pharma, marking third strategic step towards building an integrated global pharma pl.
Anupam Rasayan India Ltd (NSE: ANURAS) secures a long-term chemical supply contract with a global major, marking a significant partnership.
Anupam Rasayan India Limited (ANURAS) reports a 36% YoY revenue growth for Q1 FY27, with EBITDA margin at 26.2%.
Anupam Rasayan India Limited (ANURAS) announces a non-binding LOI with Basquevolt for potential $300 Mn specialty chemical supply over 10 years.
Anupam Rasayan India Limited (ANURAS) announces the commercial launch of ETFA, becoming the first globally to use flow chemistry.